Whole-body insulin sensitivity index is a highly specific predictive marker for virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients with genotype 1b and high viral load

Digestive Diseases and Sciences

Volumn 55, Issue 1, 2010, Pages 183-189

  Mizuta, Toshihiko ^a   Kawaguchi, Yasunori ^a   Eguchi, Yuichiro ^a   Takahashi, Hirokazu ^a   Ario, Keisuke ^a   Akiyama, Takumi ^a   Oza, Noriko ^a   Otsuka, Taiga ^a   Kuwashiro, Takuya ^a   Yoshimura, Toru ^a   Hisatomi, Akitaka ^a   Ozaki, Iwata ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis C; HOMA IR; Peginterferon plus ribavirin therapy; Soluble tumor necrosis factor receptor 2; Whole body insulin sensitivity index

Indexed keywords

GLUCOSE; PEGINTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN; TUMOR NECROSIS FACTOR RECEPTOR 2; ALPHA2B INTERFERON; ANTIVIRUS AGENT; INSULIN; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2B;

ADULT; AGED; ARTICLE; FEMALE; GENOTYPE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HEPATITIS C VIRUS; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUTROPHIL COUNT; ORAL GLUCOSE TOLERANCE TEST; PREDICTOR VARIABLE; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS LOAD; BLOOD; DRUG COMBINATION; DRUG EFFECT; GENETICS; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; SECRETION; SENSITIVITY AND SPECIFICITY; VIROLOGY;

ADULT; AGED; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; GLUCOSE TOLERANCE TEST; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INSULIN; INSULIN RESISTANCE; INTERFERON ALFA-2B; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; PREDICTIVE VALUE OF TESTS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RIBAVIRIN; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 74049087081     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0691-2     Document Type: Article

References (29)

1. MP Manns JG McHutchison SC Gordon VK Rustgi M Shiffman R Reindollar ZD Goodman K Koury M Ling JK Albrecht 2001 Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C: a randomized trial Lancet 358 958 965 10.1016/S0140- 6736(01)06102-5 10.1016/S0140-6736(01)06102-5 1:CAS:528:DC%2BD3MXntF2qtb8%3D 11583749 (Pubitemid 32913521)
2. MW Fried ML Shiffman KR Reddy C Smith G Marinos FL Gonçales Jr D Häussinger M Diago G Carosi D Dhumeaux A Craxi A Lin J Hoffman J Yu 2002 Peginterferon alfa 2a and ribavirin for chronic hepatitis C virus infection N Engl J Med 347 975 982 10.1056/NEJMoa020047 10.1056/NEJMoa020047 1:CAS:528:DC%2BD38Xnt12rtb0%3D 12324553
3. DB Strader T Wright DL Thomas LB Seeff 2004 Diagnosis, management, and treatment of hepatitis C Hepatology 39 1147 1171 10.1002/hep.20119 10.1002/hep.20119 15057920 (Pubitemid 38428955)
4. MR Charlton P Pockros SA Harrison 2006 Impact of obesity on treatment of chronic hepatitis C Hepatology 43 1177 1186 10.1002/hep.21239 10.1002/hep.21239 16729327 (Pubitemid 43980094)
5. SA Harrison 2008 Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment Clin Gastroenterol Hepatol 6 864 876 10.1016/j.cgh.2008.03.024 10.1016/j.cgh.2008.03.024 18585970
6. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner 1985 Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man Diabetologia 28 412 419 10.1007/BF00280883 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D 3899825 (Pubitemid 15018832)
7. M Matsuda R DeFronzo 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diabetes Care 22 1462 1470 10.2337/diacare.22.9.1462 10.2337/diacare.22.9.1462 1:STN:280:DyaK1MvgvVertQ%3D%3D 10480510 (Pubitemid 29418240)
8. O Ohno M Mizokami RR Wu MG Saleh K Ohba E Orito M Mukaide R Williams JY Lau 1997 New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a J Clin Microbiol 35 201 207 1:CAS:528:DyaK2sXktVKksA%3D%3D 8968908
9. KG Alberti PZ Zimmet 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 1:STN:280:DyaK1czkvFCrsA%3D%3D 9686693 (Pubitemid 28319935)
10. HS Seltzer EW Allen AL Herron Jr MT Brennan 1967 Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus J Clin Invest 46 323 335 10.1172/JCI105534 10.1172/JCI105534 1:CAS:528:DyaF2sXptlalsA%3D%3D 6023769
11. The French METAVIR Cooperative Study Group P Bedossa 1994 Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C Hepatology 20 15 20
12. M Romero-Gómez M Del Mar Viloria RJ Andrade J Salmerón M Diago CM Fernández-Rodríguez R Corpas M Cruz L Grande L Vázquez P Muñoz-De-Rueda P López-Serrano A Gila ML Gutiérrez C Pérez A Ruiz-Extremera E Suárez J Castillo 2005 Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis patients Gastroenterology 128 636 641 10.1053/j.gastro.2004.12.049 10.1053/j.gastro.2004.12.049 15765399 (Pubitemid 40585366)
13. R D'Souza A Sabin GR Foster 2005 Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy Am J Gastroenterol. 100 1509 1515 10.1111/j.1572-0241.2005.41403.x 10.1111/j.1572-0241.2005.41403.x 15984973 (Pubitemid 41032355)
14. HS Conjeevaram DE Kleiner JE Everhart JH Hoofnagle S Zacks NH Afdhal AS Wahed Virahep-C study group 2007 Race, insulin resistance and hepatic steatosis in chronic hepatitis C Hepatology 45 80 87 10.1002/hep.21455 10.1002/hep.21455 1:CAS:528:DC%2BD2sXht1arsbo%3D 17187406 (Pubitemid 46144367)
15. MA Abdul-Ghani M Matsuda B Balas RA DeFronzo 2007 Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test Diabetes Care 30 89 94 10.2337/dc06-1519 10.2337/dc06-1519 1:CAS:528: DC%2BD2sXhsFWqtb4%3D 17192339 (Pubitemid 46052504)
16. Y Shintani H Fujie H Miyoshi T Tsutsumi K Tsukamoto S Kimura K Moriya K Koike 2004 Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance Gastroenterology 126 840 848 10.1053/j.gastro.2003.11.056 10.1053/j.gastro.2003.11.056 1:CAS:528: DC%2BD2cXivFCisLw%3D 14988838 (Pubitemid 38298332)
17. V Pazienza S Clément P Pugnale S Conzelman M Foti A Mangia F Negro 2007 The Hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms Hepatology 45 1164 1171 10.1002/hep.21634 10.1002/hep.21634 1:CAS:528:DC%2BD2sXlslOju78%3D 17465001 (Pubitemid 46775778)
18. N Taura T Ichikawa K Hamasaki K Nakao D Nishimura T Goto M Fukuta H Kawashimo M Fujimoto K Kusumoto Y Motoyoshi H Shibata N Abiru H Yamasaki K Eguchi 2006 Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients Am J Gastroenterol 101 2752 2759 10.1111/j.1572-0241.2006.00835.x 1:CAS:528:DC%2BD2sXht1aqtL0%3D 17026566 (Pubitemid 44902647)
19. A Lecube C Hernández J Genescà R Simó 2006 Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study Diabetes Care 29 1096 1101 10.2337/dc05-2509 10.2337/dc05-2509 1:CAS:528:DC%2BD28XkvVKqur4%3D 16644643
20. CH Lang C Dobrescu GJ Bagby 1992 Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose uptake Endocrinology 130 43 52 10.1210/en.130.1.43 10.1210/en.130.1.43 1:CAS:528:DyaK38XlslSqtQ%3D%3D 1727716
21. Y Eguchi T Mizuta T Yasutake A Hisatomi R Iwakiri I Ozaki K Fujimoto 2006 High serum leptin is an independent risk factor for non-response in patients with low viremia to antiviral treatment in chronic hepatitis C World J Gastroenterol 12 556 560 1:CAS:528:DC%2BD28XjsFyju7s%3D 16489668
22. C Grunfeld C Zhao J Fuller A Pollack A Moser J Friedman KR Feingold 1996 Endotoxin and cytokine induce expression of leptin, the OB gene product, in hamster J Clin Invest 97 2152 2157 10.1172/JCI118653 10.1172/JCI118653 1:CAS:528:DyaK28Xislymsb0%3D 8621806
23. JM Fernández-Real M Broch W Ricart R Casamitjana C Gutierrez J Vendrell C Richart 1998 Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance Diabetes 47 1757 1762 10.2337/diabetes.47.11.1757 10.2337/diabetes.47.11.1757 9792545 (Pubitemid 28476250)
24. G Vlotides AS Sörensen F Kopp K Zitzmann N Cengic S Brand R Zachoval CJ Auernhammer 2004 SOCS-1 and SOCS-3 inhibit IFN-a-induced expression of the antiviral proteins 2,5-OAS and MxA Biochem Biophys Res Commun 320 1007 1014 10.1016/j.bbrc.2004.06.051 10.1016/j.bbrc.2004.06.051 1:CAS:528: DC%2BD2cXlsVaqsbk%3D 15240148 (Pubitemid 38887243)
25. T Kawaguchi T Yoshida M Harada T Hisamoto Y Nagao T Ide E Taniguchi H Kumemura S Hanada M Maeyama S Baba H Koga R Kumashiro T Ueno H Ogata A Yoshimura M Sata 2004 Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3 Am J Pathol 165 1499 1508 1:CAS:528:DC%2BD2cXhtVCgsLfI 15509521
26. M Persico M Capasso E Persico M Svelto R Russo D Spano L Crocè V La Mura F Moschella F Masutti R Torella C Tiribelli A Iolascon 2007 Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: insulin resistance and response to antiviral therapy Hepatology 46 1009 1015 10.1002/hep.21782 10.1002/hep.21782 1:CAS:528:DC%2BD2sXht1aksr3O 17668875 (Pubitemid 350144765)
27. G Sass ND Shembade G Tiegs 2005 Tumour necrosis factor α (TNF)-TNF receptor 1-inducible cytoprotective proteins in the mouse liver: relevance of suppressors of cytokine signaling Biochem J 385 537 544 10.1042/BJ20040279 10.1042/BJ20040279 1:CAS:528:DC%2BD2MXhvVClsw%3D%3D 15554901 (Pubitemid 40165087)
28. H Knobler A Schattner 2005 TNF-α, chronic hepatitis C and diabetes: a novel triad QJM 98 1 6 10.1093/qjmed/hci001 10.1093/qjmed/hci001 1:STN:280:DC%2BD2M%2FltVKksQ%3D%3D 15625348
29. K Overbeck D Genné A Golay F Negro 2008 Pioglitazone in chronic hepatitis C not responding to pegylated interferon-α and ribavirin J Hepatol 49 295 298 10.1016/j.jhep.2008.03.033 10.1016/j.jhep.2008.03.033 1:CAS:528:DC%2BD1cXotlWqtrk%3D 18555553